MYCL1, FHIT, SPARC, p16INK4 and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis

Journal of Cellular and Molecular Medicine

Volumn 6, Issue 2, 2002, Pages 215-222

  Demopoulos, K ^a   Arvanitis, D A ^a   Vassilakis, D A ^a   Siafakas, N M ^a   Spandidos, D A ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Idiopathic pulmonary fibrosis; Loss of heterozygosity; Microsatellite DNA

Indexed keywords

ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; MICROSATELLITE DNA; OSTEONECTIN; TUMOR PROTEIN;

ARTICLE; GENETIC MARKER; GENETICS; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; LUNG FIBROSIS; LUNG TUMOR; ONCOGENE MYC; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; GENES, MYC; GENES, P16; GENES, P53; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MICROSATELLITE REPEATS; NEOPLASM PROTEINS; OSTEONECTIN; PULMONARY FIBROSIS;

EID: 0036548319     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2002.tb00188.x     Document Type: Article

References (31)

1. Gross T.J., Hunninghake G.W., Idiopathic pulmonary fibrosis, N. Engl. J. Med., 345: 517-525, 2001
2. Ziesche R., Hofbauer E., Wittmann K., Petkov V., Block L.H., A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis, N. Engl. J. Med., 341: 1264-1269, 1999
3. Iwai K., Mori T., Yamada N., Yamaguchi M., Hosoda Y., Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure, Am. J. Respir. Crit. Care Med., 150: 670-675, 1994
4. Scott J., Johnston I., Britton J., What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust, Br. Med. J., 301: 1015-1017, 1990
5. Jakab G.J., Sequential virus infections, bacterial superinfections, and fibrogenesis, Am. Rev. Respir. Dis., 142: 374-379, 1990
6. Lok S.S., Egan J.J., Viruses and idiopathic pulmonary fibrosis, Monaldi Arch. Chest Dis., 55: 146-150, 2000
7. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS), Am. J. Respir. Crit. Care Med., 161: 646-664, 2000
8. Mageto Y.N., Raghu G., Genetic predisposition of idiopathic pulmonary fibrosis, Curr. Opin. Pulm. Med., 3: 336-340, 1997
9. Marshall R.P., McAnulty R.J., Laurent G.J., The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?, Int. J. Biochem. Cell Biol., 29: 107-120, 1997
10. Marshall R.P., Puddicombe A., Cookson W.O., Laurent G.J., Adult familial cryptogenic fibrosing alveolitis in the United Kingdom, Thorax, 55: 143-146, 2000
11. Haddad R., Massaro D., Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer, Am. J. Med., 45:211-219, 1968
12. Jones A.W., Alveolar cell carcinoma occurring in idiopathic interstitial pulmonary fibrosis, Br. J. Dis. Chest, 64: 78-84, 1970
13. Panos R.J., Mortenson R.L., Niccoli S.A., King T.E., Jr., Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment, Am. J. Med., 88: 396-404, 1990
14. Samet J.M., Does idiopathic pulmonary fibrosis increase lung cancer risk?, Am. J. Respir. Crit. Care Med., 161: 1-2, 2000
15. Kuwano K., Kunitake R., Kawasaki M., Nomoto Y., Hagimoto N., Nakanishi Y., Hara N., P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis, Am. J. Respir. Crit. Care Med., 154: 477-483, 1996
16. van den Blink B., Jansen H.M., Peppelenbosch M.P., Idiopathic pulmonary fibrosis: molecular mechanisms and possible therapeutic strategies, Arch. Immunol. Ther. Exp. (Warsz.), 48: 539-545, 2000
17. Kawasaki H., Ogura T., Yokose T., Nagai K., Nishiwaki Y., Esumi H., p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis, Hum. Pathol., 32: 1043-1049, 2001
18. Maeyama T., Kuwano K., Kawasaki M., Kunitake R., Hagimoto N., Matsuba T., Yoshimi M., Inoshima I., Yoshida K., Hara N., Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis, Eur. Respir. J., 17: 180-189, 2001
19. Vassilakis D.A., Sourvinos G., Spandidos D.A., Siafakas N.M., Bouros D., Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis, Am. J. Respir. Crit. Care. Med., 162: 1115-1119, 2000
20. Mori M., Kida H., Morishita H., Goya S., Matsuoka H., Arai T., Osaki T., Tachibana I., Yamamoto S., Sakatani M., Ito M., Ogura T., Hayashi S., Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis, Am. J. Respir. Cell Mol. Biol., 24: 398-404, 2001
21. Uematsu K., Yoshimura A., Gemma A., Mochimaru H., Hosoya Y., Kunugi S., Matsuda K., Seike M., Kurimoto F., Takenaka K., Koizumi K., Fukuda Y., Tanaka S., Chin K., Jablons D.M., Kudoh S., Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis, Cancer Res., 61: 8527-8533, 2001
22. Froudarakis M.E., Sourvinos G., Fournel P., Bouros D., Vergnon J.M., Spandidos D.A., Siafakas N.M., Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer, Chest, 113: 1091-1094, 1998
23. Bhowmik A., Seemungal T.A., Sapsford R.J., Devalia J.L., Wedzicha J.A., Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease, Thorax, 53: 953-956, 1998
24. Peltomaki P., Lothe R.A., Aaltonen L.A., Pylkkanen L., Nystrom-Lahti M., Seruca R., David L., Holm R., Ryberg D., Haugen A., et al., Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome, Cancer Res., 53: 5853-5855, 1993
25. DePinho R.A., Hatton K.S., Tesfaye A., Yancopoulos G.D., Alt F.W., The human myc gene family: structure and activity of L-myc and an L-myc pseudogene, Genes Dev., 1: 1311-1326, 1987
26. Makela T.P., Saksela K., Alitalo K., Amplification and rearrangement of L-myc in human small-cell lung cancer, Mutat. Res., 276: 307-315, 1992
27. Gasparian A.V., Laktionov K.K., Belialova M.S., Pirogova N.A., Tatosyan A.G., Zborovskaya I.B., Allelic imbalance and instability of microsatellite loci on chromosome 1p in human non-small-cell lung cancer, Br. J. Cancer, 77: 1604-1611, 1998
28. Sozzi G., Veronese M.L., Negrini M., Baffa R., Cotticelli M.G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U., Pierotti M.A., Ohta M., Huebner K., Croce C.M., The FHIT gene 3p14.2 is abnormal in lung cancer, Cell, 85: 17-26, 1996
29. Burke L., Khan M.A., Freedman A.N., Gemma A., Rusin M., Guinee D.G., Bennett W.P., Caporaso N.E., Fleming M.V., Travis W.D., Colby T.V., Trastek V., Pairolero P.C., Tazelaar H.D., Midthun D.E., Liotta L.A., Harris C.C., Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer, Cancer Res., 58: 2533-2536, 1998
30. Bradshaw A.D., Sage E.H., SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury, J. Clin. Invest., 107: 1049-1054, 2001
31. Selman M., Pardo A., Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder, Respir. Res., 3: 3, 2002